Once integration is completed, the partners plan to accelerate commercial rollout across India, anticipated in 2026.

A precision cardiovascular medicine company’s innovative AI-driven epigenetic-genetic blood tests will soon be available in one of the nation’s largest retailers. Beginning Q2 2024, Cardio Diagnostics ...

Agreement expands Cardio Diagnostics' global footprint and supports improved detection and management of coronary heart disease in India.

Management of mitochondrial-related heart disease relies on multidisciplinary care and symptom control, as targeted gene-editing therapies are limited.

Tailoring medicines to an individual’s genetic profile is now possible. One critical aspect is genetic testing that reduces side effects, particularly for patients on psychiatric and cardiovascular ...

Cardiovascular diseases (CVD) cause about one in three deaths worldwide. The World Health Organization (WHO) estimates 19.8 million CVD deaths in 2022, roughly 32% of all deaths. Care remains reactive ...

Impella, which J&J touts as the world’s smallest heart pump, has a range of devices used for various heart conditions. Lexeo ...